Microcapsules and transdermal patch: A comparative approach for improved delivery of antidiabetic drug

AAPS PharmSciTech

Volumn 10, Issue 3, 2009, Pages 928-934

  Mishra, Manoj K ^a   Ray, Debajyoti ^b   Barik, Bhakti B ^c  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^b Sri Jayadev College of Pharmaceutical Sciences   (India)

^c UTKAL UNIVERSITY   (India)

Author keywords

Bioavailability; Glibenclamide; Oral microcapsules; Pharmacokinetics; Transdermal delivery

Indexed keywords

GLIBENCLAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; FEMALE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HYPOGLYCEMIA; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MICROCAPSULE; MOUSE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PLASMA HALF LIFE; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; GLUCOSE TOLERANCE TEST; GLYBURIDE; HYPOGLYCEMIC AGENTS; MALE; MICE; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 70449521103     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9289-z     Document Type: Article

References (26)

1. A Ramachandran C Snehalatha V Viswanathan 2002 Burden of type II diabetes and its complications-the Indian scenario Curr Sci 83 1471 1476 1:CAS:528:DC%2BD3sXhtVGisLo%3D
2. J Zuckner 1986 International experience with diclofenac in rheumatoid arthritis Am J Med 4B 39 42 10.1016/0002-9343(86)90078-1 (Pubitemid 16067991)
3. F Piccinini L Rovati A Zanni A Cagnacci A Volpe F Facchhinetti 2000 Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthetase in postmenopausal women Gyaenacol Endocrinol 14 142 146 1:STN:280:DC%2BD3cvhs1Wlsw%3D%3D
4. RA Moya CF Moisa F Morales H Wynter E Narancis 2000 Transdermal glyceryl trinitrate in the management of primary dysmenorrhea Int J Gynaecol Obstet 69 113 118 10802078 10.1016/S0020-7292(00)00185-5 1:CAS:528:DC%2BD3cXivVGhsbs%3D (Pubitemid 30252036)
5. EC Ku JM Wasvary WD Cash 1975 Diclofenac sodium (GP 45840, VollarenTM) a potent inhibitor of prostaglandin synthetase Biochem Pharmacol 24 641 643 804905 10.1016/0006-2952(75)90186-0 1:CAS:528:DyaE2MXkt1agtrw%3D
6. S Lundstam E Tveit JG Kral 1983 Prostaglandin synthesis inhibition by diclofenac sodium in biliary pain Eur J Clin Investig 13 A1 10.1111/j.1365-2362. 1983.tb00055.x
7. VA John 1979 The pharmacokinetics and metabolism of diclofenac sodium (VoltarolTM) in animals and man Rheumatol Rehabil 2 22 37 119296
8. FK Gorus FC Schuit PA Intveld 1988 Interaction of sulfonyl ureas with pancreatic beta cells-a study with gliburide Diabetes 37 1090 1095 2839387 10.2337/diabetes.37.8.1090 1:CAS:528:DyaL1cXltVCmur4%3D
9. H Ikegami K Shima A Tanaka Y Tahara M Hirota 1986 Inter individual variation in the absorption of glibenclamide in man Acta Endocrinol Copenh 111 528 532 3085419 1:STN:280:DyaL283htV2ksg%3D%3D
10. S Mutalik N Udupa 2002 Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin Pharmazie 12 838 841
11. S Mutalik N Udupa 2003 Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin Pharmazie 12 891 894
12. T Pongjanyakul S Puttipipatkhachorn 2007 Xanthan-alginate composite gel beads: molecular interaction and in vitro characterization Int J Pharm 331 61 71 17046185 10.1016/j.ijpharm.2006.09.011 1:CAS:528:DC%2BD2sXht1GisLw%3D (Pubitemid 46176497)
13. TEGK Murthy VS Kishore 2007 Effect of casting solvent on permeability of antihypertensive drugs through eudragit RS 100 films Asian J Pharm 1 108 114
14. RS Al-Kassas OMN Al-Gohary MM Al-Faadhel 2007 Controlling of systemic absorption of gliclazide through incorporation into alginate beads Int J Pharm 341 230 237 17507189 10.1016/j.ijpharm.2007.03.047 1:CAS:528: DC%2BD2sXot1Clsr4%3D (Pubitemid 47088107)
15. TX Viegas AH Hikal RN Cleary 1988 Formulations of penetration enhancers in polymers Drug Devel Ind Pharm 14 855 866 10.3109/03639048809151905 1:CAS:528:DyaL1cXksl2murk%3D
16. R Anders HP Merkel 1989 Evaluation of laminated muco-adhesive patches for buccal drug delivery Int J Pharm 49 231 240 10.1016/0378-5173(89)90347-5 1:CAS:528:DyaL1MXht1Wgs7s%3D (Pubitemid 19053414)
17. S Sridevi MG Chary DR Krishna PV Diwan 2000 Pharmacodynamic evaluation of transdermal drug delivery system of glibenclamide in rats Ind J Pharmacol 32 309 312 1:CAS:528:DC%2BD3cXotlyrs7w%3D
18. H Emilsson S Sjoberg M Svedner I Christenson 1986 High performance liquid chromatographic determination of glibenclamide in human plasma and urine J Chromatogr 383 93 102 3102535 10.1016/S0378-4347(00)83445-3 1:CAS:528: DyaL2sXislartQ%3D%3D
19. Moffat AC. Clarke's isolation and identification of drugs. London: The Pharmaceutical Press; 1986.
20. C Rerup 1970 Drugs producing diabetes through damage of insulin secreting cells Pharmcol Rev 22 485 520 1:STN:280:DyaE3M%2FktlWqtQ%3D%3D
21. G Grodsky G Epstein R Fanska J Karam 1971 Pancreatic action of sulfonylureas Fed Proc 36 2719 2728
22. DCCT Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus N Eng J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
23. Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacothrapy of the endocrine pancreas. In: Hardman JG, Limbird LE, editors. The pharmacological basis of the therapeutics. 9th ed. New York: McGraw-Hill; 1996. p. 1487-517.
24. OK Faber H Beck-Neilsen C Binder 1990 Acute actions of sulfonyl urea drugs during long term treatment of non insulin dependent diabetes mellitus Diabetes Care 13 26 31 2120020
25. PO Bitzen A Melander B Schersten 1992 Long term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin dependent diabetes mellitus Eur J Clin Pharmacol 42 77 82 1541320 10.1007/BF00314924 1:STN:280:DyaK387nsFSguw%3D%3D
26. S Mutalik N Udupa 2004 Glibenclamide transdermal patches: physicochemical, pharmacodynemic, and pharmacokinetics evaluations J Pharm Sci 93 1577 1594 15124215 10.1002/jps.20058 1:CAS:528:DC%2BD2cXks12hsro%3D (Pubitemid 38725029)